"Changing the Venture Capital Paradigm: Unlocking the Value of Tech Commercialization"
Event Date: February 1st, 2018
Ikove held its first Annual Innovation Showcase on February 1, 2018 at the office of Pepper Hamilton in NYC. The event hosted over 100 investors and stakeholders from U.S. Europe, Asia, and Latin America for an evening of discovery, disruption, and innovation. Ikove plans to hold the event annually to showcase our role and the commercialization of our companies in Central Ohio and the Midwest.
The presentations included Beni Gradwohl, CEO of Cognovi Labs, Will Zell CEO of Nikola Labs, Ross Kayuha and Brian Cohen, CEO and Medical Director of ParaGen, Andrew Hulsh, Partner at Pepper Hamilton, and our keynote speaker Ian Sosso from MonteCarlo Capital.
Presented by Beni Gradwohl, CEO
Cognovi Labs is a spinoff of the Kno.e.sis Center, one of the leading artificial intelligence research departments. Cognovi focuses on identifying emotions within social media, helping understand human behavior and intents. Applications are broad and customers range from hedge funds to consumer brands and political organizations.
Presented by Ross Kayuha, CEO and Brian Cohen, Medical Director
ParaGen Technologies aims to redefine tissue engineering by addressing the problems associated with synthetic and biologic implants; while incorporating their advantages. The company is utilizing synthetic nanofiber scaffolds that promote healing by mimicking the physical structures found naturally in the body. ParaGen Technologies is launching medical device companies that tailor this technology to meet the needs of specific clinical verticals.RenovoDerm wound care devices create an environment for tissue growth and regeneration accelerating the body’s healing response. Unlike competitive products, RenovoDerm stimulates full regeneration of dermal tissue, sweat glands, and hair follicles, which play a vital functional role in healthy skin. The company received FDA approval.
RenovoDerm wound care devices create an environment for tissue growth and regeneration accelerating the body’s healing response. Unlike competitive products, RenovoDerm stimulates full regeneration of dermal tissue, sweat glands, and hair follicles, which play a vital functional role in healthy skin. The company received FDA approval.
Atreon Orthopedics is developing a nanofiber inlay to improve healing for soft tissue orthopedic repairs. The scaffold will be placed on the bone under the torn or ruptured tendon, assisting cell migrations into the bone/tendon interface. The product will allow for a quick and safe return to full activities, with a lower risk of stiffness and pain post-repair.
Vascular Genesis is building a line of cell-free, degradable, synthetic scaffold products as the foundation for vascular conduit replacement, eliminating the need for tissue donation, immune suppressants and the ever-present risk of transplant rejection.
Tarian Medical is targeting the projected $3.73B global hernia repair device market, developing a product that will encourage the growth and proliferation of cells to heal the tissue defect while reducing the formation of scar tissue and pain for the patient.
Presented by Will Zell, CEO and Founding Partner
Nikola Labs is a spinoff of Ohio State’s world-renowned Electro Science Lab. Nikola is a wireless power company that has developed a way to harvest radio frequency waves and converts them into direct current, creating a way to recharge IoT sensors remotely. The company just launched first wireless power system (PfM) aimed at the $12 billion Preventive Maintenance market.